• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AN1

ANAGENICS LIMITED - Announcements

0.00% ! 0.7¢
Market Cap $3.474M  !

Anagenics Limited is an Australia-based health and beauty-tech company that operates... Anagenics Limited is an Australia-based health and beauty-tech company that operates health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. The Company operates through its holding entity, Anagenics Limited and its main operating subsidiary company BLC Cosmetics Pty Limited (BLC) being a distributor of prestige beauty cosmetics and beauty equipment. BLC is an importer and distributor of prestige international and local skin care and wellbeing brands, namely Thalgo, Comfort Zone, Priori and other premium brands. BLC services over 1,000 spas, clinics, salons, retail stores and online in Australia, New Zealand and the Pacific Islands. The Company's brands consist of evolis and Uspa. Evolis is an anti-ageing hair care collection focused on harnessing the scientific research to give customers' thicker and healthier hair.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



AN1 AGM Presentation by CEO21/11/16 download Created with Sketch. 1.95MB
AN1 Change of Director's Interest Notice - Halasz17/11/16 download Created with Sketch. 107.61KB
AN1 Cleansing Statement & Appendix 3B09/11/16 download Created with Sketch. 263.14KB
AN1 USA launch of evolis-CDY.AX PRICE SENSITIVE03/11/16 download Created with Sketch. 91.45KB
AN1 USA launch of evolisPRICE SENSITIVE03/11/16 download Created with Sketch. 91.45KB
AN1 Cleansing Statement and Appendix 3B-CDY.AX 02/11/16 download Created with Sketch. 276.03KB
AN1 Change of Director's Interest Notice - Halasz-CDY.AX 01/11/16 download Created with Sketch. 107.27KB
AN1 ASX Market Release - Reinstatement-CDY.AX PRICE SENSITIVE01/11/16 download Created with Sketch. 81.17KB
AN1 Cellmid Capital Raising-CDY.AX 01/11/16 download Created with Sketch. 82.06KB
AN1 Appendix 4C - quarterly-CDY.AX 31/10/16 download Created with Sketch. 189.02KB
AN1 Appendix 3B-CDY.AX 28/10/16 download Created with Sketch. 457.52KB
AN1 Suspension from Official Quotation-CDY.AX PRICE SENSITIVE28/10/16 download Created with Sketch. 216.76KB
AN1 Ceasing to be a substantial holder-CDY.AX 27/10/16 download Created with Sketch. 70.59KB
AN1 Trading Halt-CDY.AX PRICE SENSITIVE26/10/16 download Created with Sketch. 221.94KB
AN1 Exercise of Options (CDYO)-CDY.AX 25/10/16 download Created with Sketch. 30KB
AN1 Appendix 3B-CDY.AX 21/10/16 download Created with Sketch. 413.17KB
AN1 Notice of Annual General Meeting/Proxy Form-CDY.AX 19/10/16 download Created with Sketch. 290.04KB
AN1 Change of Director's Interest Notice - King-CDY.AX 17/10/16 download Created with Sketch. 115.31KB
AN1 Change of Director's Interest Notice - Halasz-CDY.AX 17/10/16 download Created with Sketch. 109.98KB
AN1 Change of Director's Interest Notice - Walton-CDY.AX 17/10/16 download Created with Sketch. 113.34KB
AN1 Change of Director's Interest Notice - Gordon-CDY.AX 17/10/16 download Created with Sketch. 114.4KB
AN1 CELLMID RECORDS HIGHEST EVER QUARTERLY SALES FOR EVOLIS-CDY.AX PRICE SENSITIVE10/10/16 download Created with Sketch. 99.24KB
AN1 Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer-CDY.AX PRICE SENSITIVE05/10/16 download Created with Sketch. 110.64KB
AN1 Cellmid 2016 Annual Report to Shareholders-CDY.AX 29/09/16 download Created with Sketch. 3.65MB
AN1 Quotation of Listed Options (CDYO)-CDY.AX 28/09/16 download Created with Sketch. 87.99KB
AN1 Expiry Of Listed Options (CDYO)-CDY.AX 23/09/16 download Created with Sketch. 259.3KB
AN1 European Midkine Patent For Surgical Adhesion Allowed-CDY.AX PRICE SENSITIVE22/09/16 download Created with Sketch. 83.58KB
AN1 Change of Director's Interest Notice-CDY.AX 19/09/16 download Created with Sketch. 134.2KB
AN1 Date of Annual General Meeting-CDY.AX 13/09/16 download Created with Sketch. 81.93KB
AN1 Appendix 4G and Corporate Governance Statement-CDY.AX 31/08/16 download Created with Sketch. 647.01KB
AN1 Appendix 4E and Preliminary Final Report-CDY.AX PRICE SENSITIVE30/08/16 download Created with Sketch. 705.08KB
AN1 New Publication for Cellmid's Midkine Antibody-CDY.AX PRICE SENSITIVE09/08/16 download Created with Sketch. 116.66KB
AN1 Cellmid Investor Presentation-CDY.AX 03/08/16 download Created with Sketch. 2.27MB
AN1 Transcript of Cellmid Investor Briefing Call-CDY.AX PRICE SENSITIVE29/07/16 download Created with Sketch. 69.69KB
AN1 Appendix 4C - quarterly-CDY.AX PRICE SENSITIVE26/07/16 download Created with Sketch. 185.34KB
AN1 Ikon Legal Action,WPP-CDY.AX PRICE SENSITIVE22/07/16 download Created with Sketch. 66.88KB
AN1 Cellmid Investor Briefing-CDY.AX 21/07/16 download Created with Sketch. 106.54KB
AN1 USA Distribution Partnership for Cellmid's Evolis-CDY.AX PRICE SENSITIVE20/07/16 download Created with Sketch. 116.87KB
AN1 Change in substantial holding-CDY.AX 18/07/16 download Created with Sketch. 124.47KB
AN1 Change in substantial holding-CDY.AX 05/07/16 download Created with Sketch. 164.16KB
AN1 Change in substantial holding-CDY.AX 04/07/16 download Created with Sketch. 135.47KB
AN1 Change in substantial holding-CDY.AX 30/06/16 download Created with Sketch. 113.83KB
AN1 Change in substantial holding-CDY.AX 29/06/16 download Created with Sketch. 132.41KB
AN1 MIDKINE INTERVIEWS WITH PHARMATELEVISION PUBLISHED-CDY.AX 29/06/16 download Created with Sketch. 165.62KB
AN1 Becoming a substantial holder-CDY.AX 28/06/16 download Created with Sketch. 137.42KB
AN1 MK antibody publication and patent in bone healing-CDY.AX PRICE SENSITIVE24/06/16
AN1 MK antibody publication and patent in bone healing-CDY.AX PRICE SENSITIVE24/06/16 download Created with Sketch. 113.86KB
AN1 Change of Director's Interest Notice - Halasz-CDY.AX 20/06/16 download Created with Sketch. 131.68KB
AN1 CELLMID LAUNCHES EVOLIS PROFESSIONAL PRODUCTS-CDY.AX 14/06/16 download Created with Sketch. 86.49KB
AN1 Update on Japanese Sales-CDY.AX 26/05/16 download Created with Sketch. 82.65KB
AN1 4th MIDKINE SYMPOSIUM RESULTS-CDY.AX 11/05/16 download Created with Sketch. 104.38KB
AN1 Significant Scientific Appointment for Advisory Board Chair-CDY.AX 09/05/16 download Created with Sketch. 182.45KB
AN1 Appendix 4C - quarterly-CDY.AX PRICE SENSITIVE21/04/16 download Created with Sketch. 183KB
AN1 Midkine Strategy Update-CDY.AX PRICE SENSITIVE08/04/16 download Created with Sketch. 83.56KB
AN1 Fourth Midkine Symposium to be held in Budapest-CDY.AX 04/04/16 download Created with Sketch. 97.86KB
AN1 Transcript of Cellmid Investor Briefing29/02/16 download Created with Sketch. 94.78KB
AN1 Cellmid to Refinance RnD LoanPRICE SENSITIVE26/02/16 download Created with Sketch. 84.44KB
AN1 Appendix 4D and Half Year AccountsPRICE SENSITIVE25/02/16 download Created with Sketch. 1.68MB
AN1 Cellmid Investor Briefing23/02/16 download Created with Sketch. 97.73KB
AN1 Director Appointment/Resignation04/02/16 download Created with Sketch. 52.85KB
AN1 Appendix 4C - quarterlyPRICE SENSITIVE27/01/16 download Created with Sketch. 151.53KB
AN1 Appendix 3Y - Maria Halasz18/12/15 download Created with Sketch. 57.53KB
AN1 Cellmid receives $1.12M R&D Tax CreditPRICE SENSITIVE11/12/15 download Created with Sketch. 65.1KB
AN1 Key Antibody Patent Granted in EuropePRICE SENSITIVE01/12/15 download Created with Sketch. 78.79KB
AN1 Correction in Relation to Date of Announcement24/11/15 download Created with Sketch. 75.33KB
AN1 Japanese Patent granted for use of Midkine for Hair GrowthPRICE SENSITIVE24/11/15 download Created with Sketch. 97.57KB
AN1 Change of Director's Interest Notices19/11/15 download Created with Sketch. 51.76KB
AN1 Appendix 3B19/11/15 download Created with Sketch. 101.69KB
AN1 Results of Meeting12/11/15 download Created with Sketch. 46.64KB
AN1 AGM Presentation to Shareholders12/11/15 download Created with Sketch. 2.03MB
AN1 Company Secretary Appointment/Resignation30/10/15 download Created with Sketch. 58.69KB
AN1 Appendix 4C - quarterlyPRICE SENSITIVE27/10/15 download Created with Sketch. 331.63KB
AN1 Cellmid 2015 Annual Report to Shareholders12/10/15 download Created with Sketch. 2.13MB
AN1 Notice of Annual General Meeting/Proxy Form12/10/15 download Created with Sketch. 330.11KB
AN1 Date of Annual General Meeting28/09/15 download Created with Sketch. 55.38KB
AN1 Cleansing Statement and Appendix 3B15/09/15 download Created with Sketch. 530.36KB
AN1 Results of EGM09/09/15 download Created with Sketch. 73.41KB
AN1 EGM Presentation by CEO09/09/15 download Created with Sketch. 2.79MB
AN1 Appendix 4G and Corporate Governance Statement31/08/15 download Created with Sketch. 535.73KB
AN1 Appendix 4E and Preliminary Final ReportPRICE SENSITIVE31/08/15 download Created with Sketch. 887.57KB
AN1 Cellmid Launching Major Advertising CampaignPRICE SENSITIVE27/08/15 download Created with Sketch. 163.66KB
AN1 Appendix 3Y - Dr Edward Fintan Walton13/08/15 download Created with Sketch. 20.04KB
AN1 Cellmid appoints EAS to support US StrategyPRICE SENSITIVE12/08/15 download Created with Sketch. 258.52KB
AN1 Notice of Extraordinary General Meeting/Proxy Form10/08/15 download Created with Sketch. 265.23KB
AN1 CDY Newsletter August 201506/08/15 download Created with Sketch. 1.13MB
AN1 Cleansing Notice and Appendix 3B05/08/15 download Created with Sketch. 546.46KB
AN1 Appendix 4C - quarterlyPRICE SENSITIVE30/07/15 download Created with Sketch. 335.18KB
AN1 Cellmid raises $4M to leverage sales growthPRICE SENSITIVE30/07/15 download Created with Sketch. 84.07KB
AN1 Trading HaltPRICE SENSITIVE28/07/15 download Created with Sketch. 115.25KB
AN1 Appendix 3X - Dr Edward Fintan Walton23/07/15 download Created with Sketch. 9.51KB
AN1 Cellmid Appoints Dr Fintan Walton as Director21/07/15 download Created with Sketch. 140.42KB
AN1 Letter to Shareholders15/07/15 download Created with Sketch. 83.83KB
AN1 Cellmid Revenue Guidance UpgradePRICE SENSITIVE09/07/15 download Created with Sketch. 74.32KB
AN1 Dr Bryce Vissel to Chair Cellmid's Scientific Advisory Board07/07/15 download Created with Sketch. 103.11KB
AN1 Initial Director's Interest Notice - B Gordon01/07/15 download Created with Sketch. 185.42KB
AN1 Final Director's Interest Notice - M Rogers01/07/15 download Created with Sketch. 280.57KB
AN1 Final Director's Interest Notice - G Kaufman01/07/15 download Created with Sketch. 344.06KB
AN1 Details of Share Registry address30/06/15 download Created with Sketch. 60.87KB
AN1 US Patent for Anti-Midkine Antibodies GrantedPRICE SENSITIVE29/06/15 download Created with Sketch. 101.52KB
AN1 Cellmid Announces Brain Cancer ProgramPRICE SENSITIVE23/06/15 download Created with Sketch. 111.11KB
AN1 AGM Presentation by CEO
21/11/16 download Created with Sketch. 1.95MB
AN1 Change of Director's Interest Notice - Halasz
17/11/16 download Created with Sketch. 107.61KB
AN1 Cleansing Statement & Appendix 3B
09/11/16 download Created with Sketch. 263.14KB
AN1 USA launch of evolis-CDY.AX
03/11/16PRICE SENSITIVE download Created with Sketch. 91.45KB
AN1 USA launch of evolis
03/11/16PRICE SENSITIVE download Created with Sketch. 91.45KB
AN1 Cleansing Statement and Appendix 3B-CDY.AX
02/11/16 download Created with Sketch. 276.03KB
AN1 Change of Director's Interest Notice - Halasz-CDY.AX
01/11/16 download Created with Sketch. 107.27KB
AN1 ASX Market Release - Reinstatement-CDY.AX
01/11/16PRICE SENSITIVE download Created with Sketch. 81.17KB
AN1 Cellmid Capital Raising-CDY.AX
01/11/16 download Created with Sketch. 82.06KB
AN1 Appendix 4C - quarterly-CDY.AX
31/10/16 download Created with Sketch. 189.02KB
AN1 Appendix 3B-CDY.AX
28/10/16 download Created with Sketch. 457.52KB
AN1 Suspension from Official Quotation-CDY.AX
28/10/16PRICE SENSITIVE download Created with Sketch. 216.76KB
AN1 Ceasing to be a substantial holder-CDY.AX
27/10/16 download Created with Sketch. 70.59KB
AN1 Trading Halt-CDY.AX
26/10/16PRICE SENSITIVE download Created with Sketch. 221.94KB
AN1 Exercise of Options (CDYO)-CDY.AX
25/10/16 download Created with Sketch. 30KB
AN1 Appendix 3B-CDY.AX
21/10/16 download Created with Sketch. 413.17KB
AN1 Notice of Annual General Meeting/Proxy Form-CDY.AX
19/10/16 download Created with Sketch. 290.04KB
AN1 Change of Director's Interest Notice - King-CDY.AX
17/10/16 download Created with Sketch. 115.31KB
AN1 Change of Director's Interest Notice - Halasz-CDY.AX
17/10/16 download Created with Sketch. 109.98KB
AN1 Change of Director's Interest Notice - Walton-CDY.AX
17/10/16 download Created with Sketch. 113.34KB
AN1 Change of Director's Interest Notice - Gordon-CDY.AX
17/10/16 download Created with Sketch. 114.4KB
AN1 CELLMID RECORDS HIGHEST EVER QUARTERLY SALES FOR EVOLIS-CDY.AX
10/10/16PRICE SENSITIVE download Created with Sketch. 99.24KB
AN1 Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer-CDY.AX
05/10/16PRICE SENSITIVE download Created with Sketch. 110.64KB
AN1 Cellmid 2016 Annual Report to Shareholders-CDY.AX
29/09/16 download Created with Sketch. 3.65MB
AN1 Quotation of Listed Options (CDYO)-CDY.AX
28/09/16 download Created with Sketch. 87.99KB
AN1 Expiry Of Listed Options (CDYO)-CDY.AX
23/09/16 download Created with Sketch. 259.3KB
AN1 European Midkine Patent For Surgical Adhesion Allowed-CDY.AX
22/09/16PRICE SENSITIVE download Created with Sketch. 83.58KB
AN1 Change of Director's Interest Notice-CDY.AX
19/09/16 download Created with Sketch. 134.2KB
AN1 Date of Annual General Meeting-CDY.AX
13/09/16 download Created with Sketch. 81.93KB
AN1 Appendix 4G and Corporate Governance Statement-CDY.AX
31/08/16 download Created with Sketch. 647.01KB
AN1 Appendix 4E and Preliminary Final Report-CDY.AX
30/08/16PRICE SENSITIVE download Created with Sketch. 705.08KB
AN1 New Publication for Cellmid's Midkine Antibody-CDY.AX
09/08/16PRICE SENSITIVE download Created with Sketch. 116.66KB
AN1 Cellmid Investor Presentation-CDY.AX
03/08/16 download Created with Sketch. 2.27MB
AN1 Transcript of Cellmid Investor Briefing Call-CDY.AX
29/07/16PRICE SENSITIVE download Created with Sketch. 69.69KB
AN1 Appendix 4C - quarterly-CDY.AX
26/07/16PRICE SENSITIVE download Created with Sketch. 185.34KB
AN1 Ikon Legal Action,WPP-CDY.AX
22/07/16PRICE SENSITIVE download Created with Sketch. 66.88KB
AN1 Cellmid Investor Briefing-CDY.AX
21/07/16 download Created with Sketch. 106.54KB
AN1 USA Distribution Partnership for Cellmid's Evolis-CDY.AX
20/07/16PRICE SENSITIVE download Created with Sketch. 116.87KB
AN1 Change in substantial holding-CDY.AX
18/07/16 download Created with Sketch. 124.47KB
AN1 Change in substantial holding-CDY.AX
05/07/16 download Created with Sketch. 164.16KB
AN1 Change in substantial holding-CDY.AX
04/07/16 download Created with Sketch. 135.47KB
AN1 Change in substantial holding-CDY.AX
30/06/16 download Created with Sketch. 113.83KB
AN1 Change in substantial holding-CDY.AX
29/06/16 download Created with Sketch. 132.41KB
AN1 MIDKINE INTERVIEWS WITH PHARMATELEVISION PUBLISHED-CDY.AX
29/06/16 download Created with Sketch. 165.62KB
AN1 Becoming a substantial holder-CDY.AX
28/06/16 download Created with Sketch. 137.42KB
AN1 MK antibody publication and patent in bone healing-CDY.AX
24/06/16PRICE SENSITIVE
AN1 MK antibody publication and patent in bone healing-CDY.AX
24/06/16PRICE SENSITIVE download Created with Sketch. 113.86KB
AN1 Change of Director's Interest Notice - Halasz-CDY.AX
20/06/16 download Created with Sketch. 131.68KB
AN1 CELLMID LAUNCHES EVOLIS PROFESSIONAL PRODUCTS-CDY.AX
14/06/16 download Created with Sketch. 86.49KB
AN1 Update on Japanese Sales-CDY.AX
26/05/16 download Created with Sketch. 82.65KB
AN1 4th MIDKINE SYMPOSIUM RESULTS-CDY.AX
11/05/16 download Created with Sketch. 104.38KB
AN1 Significant Scientific Appointment for Advisory Board Chair-CDY.AX
09/05/16 download Created with Sketch. 182.45KB
AN1 Appendix 4C - quarterly-CDY.AX
21/04/16PRICE SENSITIVE download Created with Sketch. 183KB
AN1 Midkine Strategy Update-CDY.AX
08/04/16PRICE SENSITIVE download Created with Sketch. 83.56KB
AN1 Fourth Midkine Symposium to be held in Budapest-CDY.AX
04/04/16 download Created with Sketch. 97.86KB
AN1 Transcript of Cellmid Investor Briefing
29/02/16 download Created with Sketch. 94.78KB
AN1 Cellmid to Refinance RnD Loan
26/02/16PRICE SENSITIVE download Created with Sketch. 84.44KB
AN1 Appendix 4D and Half Year Accounts
25/02/16PRICE SENSITIVE download Created with Sketch. 1.68MB
AN1 Cellmid Investor Briefing
23/02/16 download Created with Sketch. 97.73KB
AN1 Director Appointment/Resignation
04/02/16 download Created with Sketch. 52.85KB
AN1 Appendix 4C - quarterly
27/01/16PRICE SENSITIVE download Created with Sketch. 151.53KB
AN1 Appendix 3Y - Maria Halasz
18/12/15 download Created with Sketch. 57.53KB
AN1 Cellmid receives $1.12M R&D Tax Credit
11/12/15PRICE SENSITIVE download Created with Sketch. 65.1KB
AN1 Key Antibody Patent Granted in Europe
01/12/15PRICE SENSITIVE download Created with Sketch. 78.79KB
AN1 Correction in Relation to Date of Announcement
24/11/15 download Created with Sketch. 75.33KB
AN1 Japanese Patent granted for use of Midkine for Hair Growth
24/11/15PRICE SENSITIVE download Created with Sketch. 97.57KB
AN1 Change of Director's Interest Notices
19/11/15 download Created with Sketch. 51.76KB
AN1 Appendix 3B
19/11/15 download Created with Sketch. 101.69KB
AN1 Results of Meeting
12/11/15 download Created with Sketch. 46.64KB
AN1 AGM Presentation to Shareholders
12/11/15 download Created with Sketch. 2.03MB
AN1 Company Secretary Appointment/Resignation
30/10/15 download Created with Sketch. 58.69KB
AN1 Appendix 4C - quarterly
27/10/15PRICE SENSITIVE download Created with Sketch. 331.63KB
AN1 Cellmid 2015 Annual Report to Shareholders
12/10/15 download Created with Sketch. 2.13MB
AN1 Notice of Annual General Meeting/Proxy Form
12/10/15 download Created with Sketch. 330.11KB
AN1 Date of Annual General Meeting
28/09/15 download Created with Sketch. 55.38KB
AN1 Cleansing Statement and Appendix 3B
15/09/15 download Created with Sketch. 530.36KB
AN1 Results of EGM
09/09/15 download Created with Sketch. 73.41KB
AN1 EGM Presentation by CEO
09/09/15 download Created with Sketch. 2.79MB
AN1 Appendix 4G and Corporate Governance Statement
31/08/15 download Created with Sketch. 535.73KB
AN1 Appendix 4E and Preliminary Final Report
31/08/15PRICE SENSITIVE download Created with Sketch. 887.57KB
AN1 Cellmid Launching Major Advertising Campaign
27/08/15PRICE SENSITIVE download Created with Sketch. 163.66KB
AN1 Appendix 3Y - Dr Edward Fintan Walton
13/08/15 download Created with Sketch. 20.04KB
AN1 Cellmid appoints EAS to support US Strategy
12/08/15PRICE SENSITIVE download Created with Sketch. 258.52KB
AN1 Notice of Extraordinary General Meeting/Proxy Form
10/08/15 download Created with Sketch. 265.23KB
AN1 CDY Newsletter August 2015
06/08/15 download Created with Sketch. 1.13MB
AN1 Cleansing Notice and Appendix 3B
05/08/15 download Created with Sketch. 546.46KB
AN1 Appendix 4C - quarterly
30/07/15PRICE SENSITIVE download Created with Sketch. 335.18KB
AN1 Cellmid raises $4M to leverage sales growth
30/07/15PRICE SENSITIVE download Created with Sketch. 84.07KB
AN1 Trading Halt
28/07/15PRICE SENSITIVE download Created with Sketch. 115.25KB
AN1 Appendix 3X - Dr Edward Fintan Walton
23/07/15 download Created with Sketch. 9.51KB
AN1 Cellmid Appoints Dr Fintan Walton as Director
21/07/15 download Created with Sketch. 140.42KB
AN1 Letter to Shareholders
15/07/15 download Created with Sketch. 83.83KB
AN1 Cellmid Revenue Guidance Upgrade
09/07/15PRICE SENSITIVE download Created with Sketch. 74.32KB
AN1 Dr Bryce Vissel to Chair Cellmid's Scientific Advisory Board
07/07/15 download Created with Sketch. 103.11KB
AN1 Initial Director's Interest Notice - B Gordon
01/07/15 download Created with Sketch. 185.42KB
AN1 Final Director's Interest Notice - M Rogers
01/07/15 download Created with Sketch. 280.57KB
AN1 Final Director's Interest Notice - G Kaufman
01/07/15 download Created with Sketch. 344.06KB
AN1 Details of Share Registry address
30/06/15 download Created with Sketch. 60.87KB
AN1 US Patent for Anti-Midkine Antibodies Granted
29/06/15PRICE SENSITIVE download Created with Sketch. 101.52KB
AN1 Cellmid Announces Brain Cancer Program
23/06/15PRICE SENSITIVE download Created with Sketch. 111.11KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $3.474M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 1544100 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 364754 3
View Market Depth
Last trade - 16.21pm 08/08/2025 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.